• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

额外少量使用利尿剂可低成本改善血压控制,且对血糖代谢无不良影响。

Additional small amounts of diuretics improve blood pressure control at low cost without disadvantages in blood sugar metabolism.

作者信息

Kudoh Toshiyuki, Nagawaga Teruhisa, Nakagawa Izumi

机构信息

Department of Cardiovascular Medicine, Wajo-kai Eniwa Hospital, Eniwa, Japan.

出版信息

Hypertens Res. 2008 Mar;31(3):455-62. doi: 10.1291/hypres.31.455.

DOI:10.1291/hypres.31.455
PMID:18497464
Abstract

We evaluated our present treatment of hypertension and sought a way to improve it. We studied 164 of outpatients we treated in 2002. Mean systolic blood pressure (SBP)+/-SD was 142.0+/-11.3, and 56% of patients had SBP over 140 mmHg. We used more diuretics in patients with good control of SBP (19% vs. 7% of patients; p=0.012). After observing our hypertensive patients, we changed our treatment in a goal-oriented manner. Our goal was blood pressure below 140/90 mmHg. We used, in principle, additional small amounts of diuretics for inadequately treated patients. We followed 147 of the 164 patients from 2002 to 2006. During this period, mean SBP decreased to 134.7+/-9.1 mmHg (p<0.001), and the frequency of patients with SBP>140 mmHg decreased to 14% (p<0.001). We used more diuretics in 2006 than in 2002 (12% to 46% p<0.001). To estimate the risks and benefits of diuretics, in 2006 we analyzed 510 patients who had been followed for at least 2 years. Potassium supplementation was needed in 28% of diuretic-treated patients and 7% of patients without diuretics. We found a correlation between the use of diuretics and good SBP control in the entire patient group as well as in patients with diabetes. In the control of diabetes mellitus, we found no statistical difference between patients treated with diuretics and those not. We found diuretics had no adverse effects with respect to new-onset diabetes mellitus.

摘要

我们评估了目前对高血压的治疗方法,并寻求改进的途径。我们研究了2002年治疗的164名门诊患者。平均收缩压(SBP)±标准差为142.0±11.3,56%的患者收缩压超过140 mmHg。在收缩压控制良好的患者中,我们使用了更多的利尿剂(19%对7%的患者;p = 0.012)。在观察高血压患者后,我们以目标导向的方式改变了治疗方法。我们的目标是血压低于140/90 mmHg。原则上,我们对治疗不充分的患者额外使用少量利尿剂。我们对164名患者中的147名从2002年随访至2006年。在此期间,平均收缩压降至134.7±9.1 mmHg(p<0.001),收缩压>140 mmHg的患者频率降至14%(p<0.001)。2006年我们比2002年使用了更多的利尿剂(12%对46%,p<0.001)。为了评估利尿剂的风险和益处,2006年我们分析了510名随访至少2年的患者。28%接受利尿剂治疗的患者和7%未使用利尿剂的患者需要补充钾。我们发现在整个患者组以及糖尿病患者中,利尿剂的使用与良好的收缩压控制之间存在相关性。在糖尿病控制方面,我们发现接受利尿剂治疗的患者与未接受治疗的患者之间没有统计学差异。我们发现利尿剂对新发糖尿病没有不良影响。

相似文献

1
Additional small amounts of diuretics improve blood pressure control at low cost without disadvantages in blood sugar metabolism.额外少量使用利尿剂可低成本改善血压控制,且对血糖代谢无不良影响。
Hypertens Res. 2008 Mar;31(3):455-62. doi: 10.1291/hypres.31.455.
2
Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.α1受体阻滞剂多沙唑嗪作为三线抗高血压药物的效用。
Hypertens Res. 2007 Apr;30(4):301-6. doi: 10.1291/hypres.30.301.
3
Current status of antihypertensive prescription and associated blood pressure control in Japan.日本抗高血压药物处方现状及相关血压控制情况
Hypertens Res. 2006 Mar;29(3):143-51. doi: 10.1291/hypres.29.143.
4
Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.α受体阻滞剂多沙唑嗪作为高血压合并糖代谢受损患者附加治疗的临床疗效及耐受性
Nutr Metab Cardiovasc Dis. 2006 Mar;16(2):137-47. doi: 10.1016/j.numecd.2005.04.005. Epub 2005 Oct 20.
5
Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).日本评估老年高血压患者最佳收缩压的试验(JATOS)的主要结果。
Hypertens Res. 2008 Dec;31(12):2115-27. doi: 10.1291/hypres.31.2115.
6
Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus.马尼地平/地拉普利与奥美沙坦/氢氯噻嗪联合治疗对老年2型糖尿病高血压患者的疗效
Hypertens Res. 2008 Jan;31(1):43-50. doi: 10.1291/hypres.31.43.
7
Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.在单用地尔硫䓬治疗未达标的高血压患者中药物的额外降压作用:一项使用诊室和家庭血压监测的随机对照试验
Clin Exp Hypertens. 2006 Oct;28(7):655-62. doi: 10.1080/10641960600946429.
8
The quality of arterial hypertension treatment in cardiology service in Kosovo--a single center study.科索沃心脏病学服务中动脉高血压治疗的质量——一项单中心研究。
Anadolu Kardiyol Derg. 2009 Apr;9(2):96-101.
9
Blood pressure reduction is not the only determinant of outcome.血压降低并非结果的唯一决定因素。
Circulation. 2006 Jun 13;113(23):2754-72; discussion 2773-4. doi: 10.1161/CIRCULATIONAHA.105.588020.
10
An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.氨氯地平/雷米普利联合用药与氨氯地平单药治疗高血压的18周前瞻性随机双盲多中心研究:氨氯地平/雷米普利联合治疗评估(ATAR)研究
Clin Ther. 2008 Sep;30(9):1618-28. doi: 10.1016/j.clinthera.2008.09.008.

引用本文的文献

1
Benefits and pitfalls of cardiovascular medication in seniors.老年人心血管药物的益处与风险
Wien Klin Wochenschr. 2013 Aug;125(15-16):425-36. doi: 10.1007/s00508-013-0395-2. Epub 2013 Jul 12.
2
Thiazide effects and adverse effects: insights from molecular genetics.噻嗪类药物的作用与不良反应:分子遗传学的见解
Hypertension. 2009 Aug;54(2):196-202. doi: 10.1161/HYPERTENSIONAHA.109.129171. Epub 2009 Jun 29.